Combination treatment with doxorubicin and gamitrinib synergistically augments anticancer activity through enhanced activation of Bim
Crossref DOI link: https://doi.org/10.1186/1471-2407-14-431
Published Online: 2014-06-13
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Park, Hye-Kyung
Lee, Ji-Eun
Lim, Jaehwa
Jo, Da-Eun
Park, Soo-Ah
Suh, Pann-Ghill
Kang, Byoung Heon
License valid from 2014-06-13
Article History
Received: 27 January 2014
Accepted: 9 June 2014
First Online: 13 June 2014